ReVance Therapeutics, Inc. (RVNC) To Release First Quarter 2014 Financial Results And Host Conference Call On Tuesday, May 13, 2014
4/30/2014 9:01:52 AM
NEWARK, Calif., April 29, 2014 (GLOBE NEWSWIRE) -- Revance Therapeutics, Inc. (Nasdaq:RVNC), a specialty biopharmaceutical company which develops botulinum toxin products for use in aesthetic and therapeutic indications, today announced that the company will release first quarter 2014 financial results on Tuesday, May 13, 2014 after the close of market. Revance will host a conference call and a live Internet webcast at 1:30pm PT/4:30pm ET on the same day to discuss the results and provide a business and clinical update.
Help employers find you! Check out all the jobs and post your resume.
comments powered by